Anonymous
Guest
Anonymous
Guest
August 5, 6 and 7th
50%+ D&R gone
Corporate level functions 70% gone(or more in some areas)
Almost all non-pharma projects canceled to fund pharma acquisitions
2 sites to be closed within 12 months, production consolidated to existing sites
Or outsourced
Manufacturing 20% head count reduction in manufacturing positions
30 to 40% in support functions
Not sure if you're making that up or have a source, but that could plausibly add to $800M.